🇺🇸 FDA
Patent

US 8658694

Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same

granted A61KA61K31/5575A61K47/02

Quick answer

US patent 8658694 (Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same) held by United Therapeutics Corporation expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United Therapeutics Corporation
Grant date
Tue Feb 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K31/5575, A61K47/02, A61K47/18, A61K47/183